Article: Wanted: Medical Isotopes.

Overcoming a critical scarcity of radioactive materials for research

Martin Brechbiel had promising results indicating that a radioactive isotope called bismuth-212 could destroy cancers in laboratory animals. Yet his work at the National Cancer Institute in Bethesda, Md., stopped short in April 1998 when his radioisotope supply suddenly dried up.

Alan R. Fritzberg at NeoRx Corp. in Seattle had also been successfully using bismuth-212 to treat cancers in animal experiments. His work, too, was stopped.

The Department of Energy's Argonne (Ill.) National Laboratory had ceased making the generators that hold radium-224, which decays into lead-212. ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!